UBI.AX - Universal Biosensors, Inc.

ASX - ASX Delayed price. Currency in AUD
Currency in AUD

Valuation measures4

Market cap (intra-day) 49.91M
Enterprise value 34.34M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.54
Price/book (mrq)1.95
Enterprise value/revenue 8.38
Enterprise value/EBITDA -1.28

Trading information

Stock price history

Beta (5Y monthly) 1.19
52-week change 3-49.47%
S&P500 52-week change 31.77%
52-week high 30.4850
52-week low 30.2100
50-day moving average 30.2567
200-day moving average 30.2639

Share statistics

Avg vol (3-month) 3102.79k
Avg vol (10-day) 3128.88k
Shares outstanding 5212.37M
Implied shares outstanding 6N/A
Float 8138.55M
% held by insiders 16.15%
% held by institutions 142.49%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-556.08%

Management effectiveness

Return on assets (ttm)-32.74%
Return on equity (ttm)-114.89%

Income statement

Revenue (ttm)4.1M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)-24.80%
Gross profit (ttm)2.14M
EBITDA -20.43M
Net income avi to common (ttm)-26.11M
Diluted EPS (ttm)-0.1200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)20.95M
Total cash per share (mrq)0.1
Total debt (mrq)5.39M
Total debt/equity (mrq)24.21
Current ratio (mrq)2.50
Book value per share (mrq)0.10

Cash flow statement

Operating cash flow (ttm)-15.26M
Levered free cash flow (ttm)-11.05M